Broker Regulation

While certain changes helped gain votes in the House, the CBO said the alterations to the AHCA bill would undermine protections for the sick and destabilize insurance markets for about a sixth of the U.S. population.

Fifteen states and the District of Columbia are trying to intervene.

Donald Trump has gone from terrifying the pharma industry with pricing criticism to increasingly conspicuous silence. A White House budget plan released this week essentially ignored drug pricing.

The Congressional Budget Office score is supposed to come out shortly. Republicans are nervous.

In this interview, Ralph Weber, President and CEO of MediBid, explores his belief that current health care pricing schemes purposefully withhold information from consumers, and why this is going to change.

According to the complaint, UnitedHealths 'chart review program' of its Medicare Advantage patients was, in reality, 'strictly a one-sided revenue-generating program.'